Video Transcript:
Good morning, I’m Dr. Breelyn Wilky from the sarcoma program at the University of Colorado Cancer Center.
Research Sarcoma Cancer Bone Cancer
Video Transcript:
Good morning, I’m Dr. Breelyn Wilky from the sarcoma program at the University of Colorado Cancer Center.
Research Prostate Cancer Bone Cancer
When prostate cancer spreads, it most often spreads to bone. And while the 5-year survival rate for prostate cancer that has not spread is nearly 100 percent, once the disease reaches bone, the 5-year survival rate is only 29 percent. Now a University of Colorado Cancer Center study published in the Journal for Immunotherapy of Cancer suggests a new approach, or, possibly two new approaches against these bone metastases: While targeted therapies and anti-cancer immunotherapies have not been especially successful against primary prostate cancers, the study suggests that both these approaches may be effective against the bone metastases that grow from primary prostate cancers, and, in fact, the type of bone metastasis may dictate which targeted therapies and immunotherapies work best.
The FDA approved Breyanzi, a CAR-T cell therapy, for the treatment of certain patients with previously treated large B-cell lymphoma.
After training a machine learning model to analyze ultrasound images of the neck, researchers tested their algorithm and have found it correctly flagged 97% of likely cancerous nodules of the thyroid gland.
Artificial intelligence (AI) can be used to identify thyroid nodules seen on thyroid ultrasound that are very unlikely to be cancerous, reducing a large number of unnecessary biopsies.
A CU Cancer Center researcher recently published a study using DNA from thousands of healthy people to help identify disease-causing mutations by using the principle of natural selection.
1665 North Aurora Court
2004
Aurora, CO 80045
720-848-0300
© 2022 The Regents of the University of Colorado, a body corporate. All rights reserved.
Accredited by the Higher Learning Commission. All trademarks are registered property of the University. Used by permission only.